Genotypic and Phenotypic Characteristics of Staphylococcus aureus Prosthetic Joint Infections: Insight on the Pathogenesis and Prognosis of a Multicenter Prospective Cohort

Authors:

Abstract
Staphylococcus aureus is the leading cause of prosthetic joint infection (PJI). Beyond the antibiogram, little attention has been given to the influence of deep microbiological characteristics on patient’s prognosis. Our aim was to investigate whether microbiological genotypic and phenotypic features have a significant influence on infection pathogenesis and patient outcome. prospective multicentre study was performed, including all S. aureus PJIs (2016-2017). Clinical data, phenotypic (agr functionality, β-hemolysis, biofilm formation) and genotypic characteristics of the strains were collected. Biofilm susceptibility to antimicrobials was investigated (MBEC assay). 88 patients (39.8% men, age 74.7±14.1 years) were included. Forty-five had early post-operative (EPI), 21 chronic (CPI), and 19 hematogenous infections (HI). Twenty (22.7%) were caused by MRSA. High genotypic diversity was observed, including 16 clonal complexes (CC), CC5 being the most frequent (30.7%). agr activity was greater in EPI than CPI (55.6% vs 28.6%, p=0.041). Strains causing EPI were phenotypically and genotypically similar, regardless of symptom duration. Treatment failure (36.5%) occurred less frequently among cases treated with implant removal. In cases treated with debridement and implant retention, there were fewer failures among those who received combination therapy with rifampin. No genotypic or phenotypic characteristics predicted failure, except vancomycin MIC>=1.5 mg/L (23.1% failure vs 3.4%, p=0.044). MBEC50 was >128 mg/L for all antibiotics tested and showed no association with prognosis. S. aureus with different genotypic backgrounds is capable of causing PJI, showing slight differences in clinical presentation and pathogenesis. No major microbiological characteristics were observed to influence the outcome, including MBEC.
Funding Information
  • Planes Nacionales de I+D+i (PI18/01623)
  • Instituto de Salud Carlos III (JR 18/00048, CM19/00226)
  • Subdirección General de Redes y Centros de Investigación Cooperativa
  • Ministerio de Economía y Competitividad
  • Spanish Network for Research in Infectious Diseases (RD16/0016/0002, PI15/02013)
  • European Development Regional Fund
  • Spanish Society of Infectious Diseases and Microbiology

This publication has 40 references indexed in Scilit: